2018
DOI: 10.1007/s40944-018-0195-8
|View full text |Cite
|
Sign up to set email alerts
|

Wound Dehiscence and Role of Delayed Primary Closure in Gynaecological Oncology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…Patients with comorbidities that affect wound healing such as diabetes, smoking, and long-term glucocorticoid use could benefit from the use of DPC. 55 One study published in the gynecologic oncology literature shows that patients who underwent DPC due to one or more existing comorbidities had no wound dehiscence compared with 27.3% dehiscence in the group that underwent primary closure. 55 However, it is important to note that in addition to the study’s small sample size (DPC, n=6) resulting in its exclusion from our comparative analysis, the statistical significance was not reported, further limiting its interpretation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Patients with comorbidities that affect wound healing such as diabetes, smoking, and long-term glucocorticoid use could benefit from the use of DPC. 55 One study published in the gynecologic oncology literature shows that patients who underwent DPC due to one or more existing comorbidities had no wound dehiscence compared with 27.3% dehiscence in the group that underwent primary closure. 55 However, it is important to note that in addition to the study’s small sample size (DPC, n=6) resulting in its exclusion from our comparative analysis, the statistical significance was not reported, further limiting its interpretation.…”
Section: Discussionmentioning
confidence: 99%
“…55 One study published in the gynecologic oncology literature shows that patients who underwent DPC due to one or more existing comorbidities had no wound dehiscence compared with 27.3% dehiscence in the group that underwent primary closure. 55 However, it is important to note that in addition to the study’s small sample size (DPC, n=6) resulting in its exclusion from our comparative analysis, the statistical significance was not reported, further limiting its interpretation. Nevertheless, it does shed some light on the possible benefits of DPC in highly comorbid patients and more importantly paves the way for future studies to better investigate this domain.…”
Section: Discussionmentioning
confidence: 99%